News Details

(As on May 15, 2025, 17:32)

Back

Bal Pharma Ltd - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company And Recommendation Of Divi

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. Audited financial results for the quarter and financial year ended 31.03.2025.\r\n2. Audited standalone and consolidated accounts of the Company together with reports of Directors and auditors there on.\r\n3. Recommendation of Dividend if any, for the financial year 2024.25.\r\n4.Appointment of Internal Auditors and Cost Auditors for the financial year 2025.26\r\n5. Appointment of Secretarial Auditors for five consecutive years , subject to the approval of shareholders.

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING